文献速递糖尿病

心脏自主神经病变可预测1型糖尿病患者的肾功能下降:一项15年随访研究

Cardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study.
PubMed 文献 · Diabetologia · 2026-07-29

结果显示,基线确诊的心脏自主神经病变(CAN)是eGFR加速下降和尿白蛋白/肌酐比(UACR)升高的独立预测因素,且CAN严重程度与KDIGO慢性肾脏病进展预后风险更高相关。

要点

  • 基线CAN是1型糖尿病eGFR加速下降的独立预测因素(p=0.018)。
  • 基线CAN是UACR升高的独立预测因素(p=0.002)。
  • CAN严重程度越高,KDIGO慢性肾脏病进展预后风险类别越高(r=0.38, p<0.001)。

核心结论

  • CAN是1型糖尿病中eGFR加速下降和白蛋白尿增加的独立预测因素。

主要发现

  • 基线确诊CAN者平均(SD)eGFR下降14.8(21.6)ml/min per 1.73 m2,而早期CAN者和无CAN者分别下降3.1(7.3)和3.3(7.4)ml/min per 1.73 m2(p=0.004)。
  • 无CAN、早期CAN和确诊CAN者的UACR平均(SD)增加分别为0.4(0.9)、11.3(30.4)和4(8.9)mg/mmol(p=0.03)。
  • 校正潜在混杂因素后,基线CAN与eGFR加速下降(p=0.018)和UACR升高(p=0.002)独立相关。
  • 基线KDIGO风险类别越高,CAN严重程度越高(r=0.38, p<0.001),UACR也越高(p<0.001)。

临床怎么用

  • 对1型糖尿病患者可考虑评估CAN,以识别肾功能下降高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to determine whether cardiac autonomic neuropathy (CAN) is an independent risk factor for kidney function decline in type 1 diabetes mellitus over a 15 year follow-up period. METHODS: Eighty seven participants with type 1 diabetes and eGFR >30 ml/min per 1.73 m2 underwent cardiovascular autonomic reflex testing at baseline. Renal data were retrieved at 4 year intervals over 15 years. Stratification of participants into Kidney Disease: Improving Global Outcomes (KDIGO) chronic kidney disease progression prognostic risk was done by using eGFR and urinary albumin/creatinine ratio (UACR). Longitudinal changes in eGFR and UACR were analysed using linear mixed-effects models with adjustment for potential confounders to determine whether CAN is an independent predictor of eGFR and UACR change over 15 years. RESULTS: At baseline, higher KDIGO risk category was associated with increased severity of CAN (r=0.38, p<0.001) and increase in UACR (p<0.001) compared with the lower risk group. Participants with established CAN at baseline exhibited greater mean (SD) eGFR decline of 14.8 (21.6) ml/min per 1.73 m2, compared with 3.1 (7.3) and 3.3 (7.4) ml/min per 1.73 m2 in the early stage and those without CAN (p=0.004). Mean (SD) increases in UACR were 0.4 (0.9), 11.3 (30.4) and 4 (8.9) mg/mmol for no CAN, early CAN and established CAN (p=0.03), respectively. After adjusting for potential confounders, baseline CAN was independently associated with both accelerated eGFR decline (p=0.018) and greater increases in UACR (p=0.002) over time. CONCLUSIONS/INTERPRETATION: CAN is an independent predictor of both accelerated eGFR decline and increased albuminuria in type 1 diabetes. The study also explored the relationship between CAN and KDIGO prognostic risk in diabetic kidney disease, demonstrating that increased severity of CAN is associated with higher KDIGO prognostic risk.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Soe KK, Robinson E, Oleolo M, et al. Cardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study. Diabetologia. 2026. PMID: 42525138. doi:10.1007/s00125-026-06818-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。